Takashi Akazawa

5PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 24, 2024
Prediction for oxaliplatin-induced liver injury using patient-derived liver organoids.

Kumiko Tatsumi, Hiroshi Wada, Shinichiro Hasegawa

|Feb 09, 2024
Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG-E8.

Yu Mizote, Takako Inoue, Takashi Akazawa

|Oct 10, 2023
In vivo transfection of cytokine genes into tumor cells using a synthetic vehicle promotes antitumor immune responses in a visceral tumor model.

Shunichi Watanabe, Ayaka Takagi, Eiji Yuba

|Mar 26, 2018
Development of a vaccine based on bacteria-mimicking tumor cells coated with novel engineered toll-like receptor 2 ligands.

Takashi Akazawa, Toshimitsu Ohashi, Viskam Wijewardana

Pageof 1